A role for up-regulated GRK2 leading to impaired catecholamine responsiveness has been shown in various animal models of cardiac disease including cardiac hypertrophy, whereas inhibiting GRK2 function enhances signaling downstream of beta-adrenergic receptors (βAR) and leads to improved catecholamine sensitivity [24]. This evidence concerns the gene GRK2 and cardiac hypertrophy.